Progesterone Receptors

CP8754 is a selective antagonist of the human progesterone receptor (hPR), acting primarily by competitively inhibiting the binding of [3H]-progesterone. This compound effectively impedes progesterone-mediated signaling, as evidenced by its ability to inhibit both exogenous luciferase and endogenous alkaline phosphatase expression in vitro, and to suppress rabbit endometrial transformation in vivo. CP8754 exhibits minimal binding affinity for human glucocorticoid receptors, estrogen receptors, and rat androgen receptors, making it a valuable tool for investigating progesterone-related diseases, including breast cancer, endometriosis, uterine fibroids, and hormone-dependent tumors.

ORG 33628 is a potent and selective progesterone receptor modulator with significant anti-progestational and anti-glucocorticoid properties. This compound exhibits ovulation-inhibitory activity, making it valuable for research in reproductive biology. ORG 33628 has potential applications in the study of conditions related to the breast and endometrium, contributing to insights into hormonal regulation and related therapeutic strategies.

Gestonorone Capronate is a synthetic progestin that primarily targets the progesterone receptor. It exhibits significant biological activity in regulating hormonal balance, making it useful in the treatment of conditions such as benign prostatic hypertrophy and endometrial cancer. This compound is valuable for research applications related to hormone signaling pathways and therapeutic interventions in progestin-responsive malignancies.